Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents
- PMID: 286311
- PMCID: PMC383237
- DOI: 10.1073/pnas.76.3.1293
Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents
Abstract
Human promyelocytic leukemia cells (HL-60) were induced to differentiate into mature cells by the tumor-promoting agent phorbol-12-myristate-13-acetate and other related phorbol diesters. Differentiation was determined by an increase in the percent of myelocytes, metamyelocytes, and other mature myeloid cells as well as by an increase in the percent of phagocytizing cells. Induction of differentiation could be determined after 2 days of treatment with phorbol-12-myristate-13-acetate at a dose as low as 6 X 10(11) M. A correlation was found between reported tumor-promoting activity of a series of phorbol esters and their ability to induce myeloid differentiation and to inhibit cell growth. It is suggested that tumor-promoting agents like chemicals that induce terminal differentiation in these cells, at extremely low concentrations, may be used as a tool in the study of the control of cell growth, cell differentiation, and malignancy in human leukemic cells.
Similar articles
-
The effect of tumor-promoting phorbol diesters on terminal differentiation of cells in culture.Mol Cell Biochem. 1980 Aug 16;31(3):165-75. doi: 10.1007/BF00225849. Mol Cell Biochem. 1980. PMID: 6934372
-
Alterations in polyamine levels induced by phorbol diesters and other agents that promote differentiation in human promyelocytic leukemia cells.Proc Natl Acad Sci U S A. 1981 Feb;78(2):1062-6. doi: 10.1073/pnas.78.2.1062. Proc Natl Acad Sci U S A. 1981. PMID: 6940123 Free PMC article.
-
Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.Proc Natl Acad Sci U S A. 1979 Oct;76(10):5158-62. doi: 10.1073/pnas.76.10.5158. Proc Natl Acad Sci U S A. 1979. PMID: 291929 Free PMC article.
-
In vitro studies on the mechanism of tumor promoter-mediated inhibition of cell differentiation.Carcinog Compr Surv. 1982;7:359-77. Carcinog Compr Surv. 1982. PMID: 7039831 Review. No abstract available.
-
The role of phorbol esters in the control of the proliferation and differentiation of hematopoietic cells.Haematologica. 1983 May-Jun;68(3):411-26. Haematologica. 1983. PMID: 6411535 Review. No abstract available.
Cited by
-
Disconnection of genes coding for self-renewal and differentiation: a possible mechanism of diversity in acute myeloid leukemias.Blut. 1985 May;50(5):257-65. doi: 10.1007/BF00319751. Blut. 1985. PMID: 3857946 No abstract available.
-
Migfilin and filamin as regulators of integrin activation in endothelial cells and neutrophils.PLoS One. 2011;6(10):e26355. doi: 10.1371/journal.pone.0026355. Epub 2011 Oct 17. PLoS One. 2011. PMID: 22043318 Free PMC article.
-
Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen.J Exp Med. 1983 Mar 1;157(3):1064-9. doi: 10.1084/jem.157.3.1064. J Exp Med. 1983. PMID: 6220104 Free PMC article.
-
Reactivation of ribosomal RNA genes in human-mouse hybrid cells by 12-O-tetradecanoylphorbol 13-acetate.Proc Natl Acad Sci U S A. 1980 Mar;77(3):1566-9. doi: 10.1073/pnas.77.3.1566. Proc Natl Acad Sci U S A. 1980. PMID: 6246494 Free PMC article.
-
Transcriptional targeting of sphingosine-1-phosphate receptor S1P2 by epigallocatechin-3-gallate prevents sphingosine-1-phosphate-mediated signaling in macrophage-differentiated HL-60 promyelomonocytic leukemia cells.Onco Targets Ther. 2014 May 7;7:667-77. doi: 10.2147/OTT.S62717. eCollection 2014. Onco Targets Ther. 2014. PMID: 24855377 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
